A phase 1 study of safety, tolerability and pharmacokinetics of acute administration of oral Liraglutide in healthy participants

The aim is to investigate the oral absorption of Liraglutide in healthy adults. The proposed works includes 1) obtaining ethical and MHRA approval (as it is a medicinal product), 2) conducting the study which involves 10 participants and 12 study visits in total where update will be assessed over 12 hours, and, 3) a report for the company